Genetic Tests Generally Agree on Breast Cancer Prognosis - CME Teaching Brief� - MedPage Today
Review
CHAPEL HILL, N.C., Aug. 9 -- Geneticists are coming to general agreement that they know the future of a breast tumor when they see it.
Four of the five available genetic tests to predict cancer recurrence or death of individual patients are in concordance even though each uses a gene set largely distinct from the others for expression profiles, said geneticist Charles M. Perou, Ph.D., of the University of North Carolina Lineberger Comprehensive Cancer Center, and colleagues.
When they applied the five tests to tumor samples from 295 patients, the investigators found that four agreed in their predictions of cancer recurrence or death of individual patient, they reported in the Aug. 10 issue of the New England Journal of Medicine.
Posted by gruwell at August 10, 2006 5:28 AM | TrackBack